π HORIBA Symposium Hall, International Science Innovation Building, Kyoto University, Kyoto, Japan ποΈ April 12β14, 2027
ProMediCon 2027 is delighted to welcome researchers, clinicians, healthcare professionals, industry leaders, innovators, and policymakers from around the world to the historic city of Kyoto, Japan. Hosted at the prestigious HORIBA Symposium Hall within Kyoto University's International Science Innovation Building, the conference aims to foster interdisciplinary collaborations that drive the future of medicine, healthcare technologies, biomedical sciences, and translational research.
Founded in 1897, Kyoto University is one of Asia's most respected institutions of higher learning and a global leader in scientific discovery. Renowned for its culture of academic freedom and innovation, the university has nurtured numerous Nobel Prize laureates and world-changing discoveries across medicine, chemistry, physics, and life sciences. Notable medical breakthroughs associated with Kyoto University include pioneering work in immunotherapy and regenerative medicine, including Nobel Prize-winning research by Prof. Tasuku Honjo and Prof. Shinya Yamanaka, whose discoveries have transformed modern healthcare and biomedical research worldwide.
The conference venue, the International Science Innovation Building, was specifically established to promote collaboration among academia, industry, government, and international research organizations. As a hub for innovation and knowledge creation, it provides an ideal environment for scientific exchange and partnership development.
Unlike traditional conferences focused only on discovery or clinical outcomes, PROMEDICON 2027 is intentionally positioned at the high-impact translational stage where therapeutic innovation becomes reality.
Exploring how artificial intelligence, computational chemistry, translational medicine, and advanced therapeutics are reshaping the future of healthcare innovation.
Designing, optimizing, and translating drug candidates into therapeutic solutions.
Combining AI, machine learning, and computational sciences with medicinal chemistry.
Advancing targeted medicines and next-generation therapeutic technologies.
Building international scientific partnerships and translational innovation ecosystems.
Discover the latest breakthroughs in medicinal chemistry, AI-driven discovery, and precision therapeutics.
April is one of the most beautiful times to visit Kyoto. During this season, the city is adorned with the breathtaking blossoms of Sakura (Cherry Blossoms), one of Japan's most cherished cultural symbols. The blooming Sakura represents renewal, hope, and the pursuit of excellenceβvalues that closely align with the spirit of scientific discovery.
Conference participants will have the opportunity to experience Kyoto's world-famous cherry blossom landscapes, historic temples, traditional gardens, and cultural heritage. The combination of scientific exchange and cultural immersion creates a truly memorable conference experience, fostering meaningful interactions and networking opportunities in an inspiring environment.
ProMediCon 2027 aims to serve as a global platform for sharing knowledge, fostering collaborations, and accelerating innovations that improve human health and well-being. By bringing together experts from academia, healthcare, industry, and government, the conference seeks to promote interdisciplinary solutions to the challenges facing modern medicine.
Join us in Kyoto, where scientific excellence, innovation, culture, and global collaboration come together to inspire the next generation of medical breakthroughs.